MOH — authorised 19 June 1970
- Marketing authorisation holder: SCHERING
- Status: likely_approved
MOH authorised Garamycin on 19 June 1970
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Yes. MOH authorised it on 19 June 1970.
SCHERING holds the Israeli marketing authorisation.